Iaci, J. F., Parry, T. J., Huang, Z., Pavlopoulos, E., Finklestein, S. P., Ren, J., & Caggiano, A. (2015). An optimized dosing regimen of cimaglermin (neuregulin 1β3, glial growth factor 2) enhances molecular markers of neuroplasticity and functional recovery after permanent ischemic stroke in rats. J Neurosci Res.

Iaci, Jennifer F., Tom J. Parry, Zhihong Huang, Elias Pavlopoulos, Seth P. Finklestein, Jingmei Ren, and Anthony Caggiano. "An Optimized Dosing Regimen of Cimaglermin (neuregulin 1β3, Glial Growth Factor 2) Enhances Molecular Markers of Neuroplasticity and Functional Recovery After Permanent Ischemic Stroke in Rats." J Neurosci Res 2015.

Iaci, Jennifer F., et al. "An Optimized Dosing Regimen of Cimaglermin (neuregulin 1β3, Glial Growth Factor 2) Enhances Molecular Markers of Neuroplasticity and Functional Recovery After Permanent Ischemic Stroke in Rats." J Neurosci Res 2015.